James Kelly, writing in the
Seoul Times, has a
most intriguing article about how the research community is tragically tied to the profit-oriented medical and pharmaceutical industries -- and how this hurts the cause of the most hopeful of medical treatments; i.e. the use of "adult" stem cells.